The study, published in Gastroenterology, shows TissueCypher can increase the detection of Barrett’s esophagus patients with an initial diagnosis of low-grade dysplasia who will progress to.
In the study, management decisions were simulated to determine the most likely care plan with or without use of the TissueCypher test for guidance
Study data shows TissueCypher test results.
New data demonstrate the risk-stratification performance and potential of the TissueCypher® Barrett’s Esophagus test to guide risk-aligned patient care decisions
. | May 26, 2023